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Abstract
CD8
+ T cells play an essential role in the protection against both acute as well as chronic Toxoplasma gondii infection.
Although the role of IL-15 has been reported to be important for the development of long-term CD8
+ T cell immunity
against the pathogen, the simultaneous roles played by both IL-15 and related c-chain family cytokine IL-7 in the generation
of this response during acute phase of infection has not been described. We demonstrate that while lack of IL-7 or IL-15
alone has minimal impact on splenic CD8
+ T cell maturation or effector function development during acute Toxoplasmosis,
absence of both IL-7 and IL-15 only in the context of infection severely down-regulates the development of a potent CD8
+ T
cell response. This impairment is characterized by reduction in CD44 expression, IFN-c production, proliferation and
cytotoxicity. However, attenuated maturation and decreased effector functions in these mice are essentially downstream
consequences of reduced number of antigen-specific CD8
+ T cells. Interestingly, the absence of both cytokines did not
impair initial CD8
+ T cell generation but affected their survival and differentiation into memory phenotype IL-7Ra
hi cells.
Significantly lack of both cytokines severely affected expression of Bcl-2, an anti-apoptotic protein, but minimally affected
proliferation. The overarching role played by these cytokines in eliciting a potent CD8
+ T cell immunity against T. gondii
infection is further evidenced by poor survival and high parasite burden in anti IL-7 treated IL-15
2/2 mice. These studies
demonstrate that the two cytokines, IL-7 and IL-15, are exclusively important for the development of protective CD8
+ T cell
immune response against T. gondii. To the best of our knowledge this synergism between IL-7 and IL-15 in generating an
optimal CD8
+ T cell immunity against intracellular parasite or any other infectious disease model has not been previously
reported.
Citation: Bhadra R, Guan H, Khan IA (2010) Absence of Both IL-7 and IL-15 Severely Impairs the Development of CD8
+ T Cell Response against Toxoplasma
gondii. PLoS ONE 5(5): e10842. doi:10.1371/journal.pone.0010842
Editor: Pierre Bobe ´, Institut Jacques Monod, France
Received February 3, 2010; Accepted May 2, 2010; Published May 26, 2010
Copyright:  2010 Bhadra et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health Grant AI33325 awarded to IAK. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mtmixk@gwumc.edu
Introduction
Development of effective CD8
+ T cell response is critical for the
control of various intracellular pathogens including, T. gondii,a n
obligate intracellular parasite [1,2]. Although both CD4
+ and
CD8
+ T cell response is induced during acute T. gondii infection,
long-term protection against the parasite is primarily dependent
on CD8
+ T cell subset [3]. Immune CD8
+ T cells from T. gondii
infected host are important source of IFN-c, a cytokine which is
critical for survival against both acute as well as chronic phases of
infection [3]. Moreover, CD8
+ T cells from T. gondii infected hosts
have the ability to exhibit in vitro cytotoxic activity against
parasite-infected targets [4]. The cytotoxic function of these
antigen-specific CD8
+ T cells has been reported to play an
important role in keeping chronic infection under control [5].
Depletion of either IFN-c or CD8
+ T cells abrogates protective
immunity against T. gondii infection leading to morbidity or
mortality of infected host.
Although importance of CD8
+ T cell immunity against T. gondii
infection is well established, the cytokines precisely involved in
generating this response have not been well demonstrated.
Previous studies from our laboratory have reported that exogenous
treatment of infected mice with IL-7 augments CD8
+ T cell
response against T. gondii resulting in their ability to survive lethal
infection [6]. In subsequent studies we reported that neutralization
of endogenous IL-15 compromises memory CD8
+ T cell response
in the T. gondii infected animals which lose their ability to survive
re-challenge [6,7]. IL-7, IL-15 and IL-2 are members of the c-
chain family of cytokines that have been implicated in the process
of memory CD8
+ T cell generation [2,8,9]. While IL-7 plays an
important role in providing survival signals to naı ¨ve and memory
CD8
+ T cells, IL-15 is believed to be crucial for driving basal
proliferation of memory CD8
+ T cells [10]. Although the role of
IL-15 in memory CD8
+ T cell development during Toxoplasma
infection has been addressed, its importance in the induction of
CD8
+ T cell response during acute phase has not been evaluated
[7,11,12]. Similarly while a previous study from our laboratory
using exogenous IL-7 treatment showed increased CTL response
in T. gondii infected mice, importance of endogenous cytokine in
eliciting this response has not been well studied [6]. Moreover, the
roles of both IL-7 and IL-15 in the induction of primary CD8
+ T
cell response has not been evaluated in models of primary
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10842infection. A study by Chang et al which demonstrates that effector
and memory T cell lineage imprinting can occur as early as the
first cell division underscores the need for understanding the
determinants of CD8
+ T response during the early phase of the
response [13]. In the present study we assayed the development of
primary CD8
+ T cell immunity against T. gondii infection in IL-15
deficient mice that are depleted of IL-7. We demonstrate that
while lack of IL-7 or IL-15 alone had minimal effect on CD8
+ T
cell immunity, the absence of both cytokines severely impacted this
response against the pathogen.
Materials and Methods
Mice, infections and antibody treatment
Animal studies were carried out in agreement with Institutional
Animal Care and Use Committee approved guidelines at George
Washington University Medical Center. 6 to 8 week old female IL-
15
2/2 mice (Taconic Farms) and C57BL/6 mice (NCI) were
infected per-orally with 10 cysts of ME49 strain (Figure. 1–6) of T.
gondii. CD8
+ T cell responses were evaluated at day 14 post-
infection (p.i.). Anti IL-7 antibody (M25) was a kind gift from
Amgen. The antibody was injected into wild-type or IL-15
2/2 i.p.
(intraperitoneally) at 0.5 mg per mouse at 3-day intervals. The
treatment was initiated one day before infection and continued till
termination of experiment. Control mice were injected with equal
volume of saline. For some experiments, IL-15
2/2 and anti IL-7
treated IL-15
2/2 animals were infected i.p. with 1610
6 cps1-1
parasites (Figure. 7) and CD8
+ T cell responses were evaluated at
day 14 p.i..
Toxoplasma Lysate Antigen (TLA) preparation
TLA was extracted from RH strain of parasite and preparation
was made as previously described [14].
Lymphocyte isolation, cell surface staining and
intracellular staining
Lymphocytes were isolated from spleen or liver as reported
earlier [11]. Antibodies for detection of IL-7Ra (CD127; A7R34),
CD8b (H35-17.2), CD44 (IM7), IL-2 (JES6-5H4), Eomesodermin
(Eomes; 21Mags8), NK1.1 (PK136) and IFN-c (XMG1.2) were
purchased from eBioscience. Antibodies against CD3 (145-2C11),
Ki-67 (B56), Bcl-2 (3F11), IL-12p40 (C15.6), IL-12Rb1 (114) and
IL-12Rb2 (HAM10B9) were purchased from BD Biosciences.
Antibody for T-bet (4B10) detection was purchased from Santa
Cruz Biotechnology. For cytokine detection, restimulation was
carried out for 12 h with 30 mg/ml of Toxoplasma lysate antigen
(TLA) in supplemented DMEM at 37u Ci n5 %C O 2.1ml/ml of
monensin (BD Biosciences) was added during the final 8 h of
stimulation. This was followed by surface staining and then
intracellular staining as described before [7]. IL-12 detection was
similarly performed but without exogenous TLA stimulation. For
IFNc detection by anti CD3 stimulation, splenocytes were plated
on anti CD3 (BD Biosciences) coated plates for 4 h with 0.65 ml/
ml brefeldin A (BD Biosciences) and 0.65 ml/ml monensin (BD
Biosciences) and staining was performed as above. Cell fluores-
cence was measured with a FACSCalibur (BD Biosciences)
cytometer and data was analyzed using FlowJo (TreeStar, Inc.)
software. Numbers in histograms or dot plots indicate percentage
unless otherwise mentioned. MFI denotes Mean Fluorescence
Intensity.
BrdU injection and staining
BrdU (BD Biosciences) was injected at 1 mg/mouse i.p. once
daily between day 2 and day 5 p.i.. Splenocytes were analyzed for
BrdU incorporation at day 6 and day 14 p.i.. Surface staining was
followed by intracellular staining. The latter was performed using
FITC BrdU Flow Kit (BD Biosciences) as per manufacturer’s
protocol. For cytokine detection restimulation was performed
using a modified protocol. Restimulation was carried out for 15 h
with 30 mg/ml of Toxoplasma lysate antigen (TLA) in supple-
mented DMEM at 37u Ci n5 %C O 2. 0.65 ml/ml of brefeldin A
(BD Biosciences) and 0.65 ml/ml monensin (BD Biosciences) was
added during the final 9 h of stimulation.
Quantification of Parasite Load
Quantification of parasite load in spleen, lung, gut and liver was
performed at day 14 p.i. as described earlier [11]. DNA was
isolated from tissues with the Qiamp tissue kit (QIAGEN,
Valencia, CA) according to the manufacturer’s instructions.
Parasite DNA was amplified with primers specific for a 35-fold
repetitive sequence of the B1 gene (59-TCTTTAAAG-
CGTTCGTGGTC-39 and 59-GGAACTGCATCCGTTCAT-
GAG-39), which is found in all known parasite strains [15]. A
134-bp competitive internal standard containing the same primer
template sequences as the 194-bp B1 PCR fragment was
synthesized, and amplified along with parasite DNA. Amplifica-
tion was performed using a 50 ml reaction mixture containing
1.24 U Amplitaq DNA polymerase, 1X PCR buffer (Promega,
Madison, WI), 0.2 mM each of dGTP, dATP, dTTP, and dCTP,
and 0.4 mM of each B1 primer. For each reaction, a known
amount of DNA from the tissues was amplified with varying
amounts of the internal standard. The levels of parasite load were
estimated by comparison to the internal controls.
Cytotoxic T lymphocyte (CTL) assay
CTL assay was performed as previously described [6]. Briefly
CD8
+ T cells stimulated TLA were incubated with infected
51Cr
labeled macrophages at various effector-target ratio in 96 well U-
bottomed plates. After 4 hr incubation the supernatants were
measured for radioactive release and percentage of cytotoxic
response calculated.
Statistical analysis
Differences in percentage, absolute number, MFI and parasite
burden were evaluated using Student’s t test with P,.05 taken as
statistically significant. Error bars in graphs represent standard
deviation of values of individual mice in the group from one
experiment. Comparison of survival curves was performed using
Log-rank (Mantel-Cox) Test. For statistical analysis of CTL data,
2-way ANOVA was used. All computations were performed using
GraphPad Prism Software.
Results
Anti IL-7 treated KO mice fail to mount a potent splenic
CD8
+ T cell response
To determine the role of IL-7 and IL-15 in the induction of
primary CD8
+ T cell response against T. gondii infection, anti IL-7
antibody was administered to WT and IL-15
2/2 mice infected
with T. gondii. Since a previous study has demonstrated
significantly increased CD44 on T cells as early as 1 week post
parasite challenge [16], T cell activation in these animals was
evaluated by measuring the surface expression of this molecule.
While naı ¨ve wild-type (WT) mice had a higher percentage of
CD44
int/hi CD8
+ T cells than uninfected IL-15 knock-out (KO)
mice, we did not observe significant differences in CD44
int/hi
frequency between infected WT and KO mice. Since IL-7 is
considered to be important for prolonged survival of naı ¨ve CD8
+
CD8 Response Development
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lead to defective CD8
+ T cell activation in these animals [17].
Interestingly, as shown in Figure. 1A, anti IL-7 antibody treatment
of WT mice did not result in attenuation of CD8
+ T cell response
against T. gondii. This is consistent with similar findings reported
by Ku et al in a non-infectious disease model where treatment of
Figure 1. Impaired CD8
+ T cell response in anti IL-7 treated KO mice. Splenocytes were harvested from WT, KO, anti IL-7 treated WT and anti
IL-7 treated KO mice at day 14 p.i. A, Percentage of CD44
int/hi cells in the CD8
+ T cell population depicted as bar graph was enumerated by surface
staining the splenocytes for CD8b and CD44. B–C, For IFNc production, cells were stimulated in vitro with TLA and after overnight incubation stained
for CD8b, CD44 and IFN-c as described in Materials and Methods. Data are presented as absolute number of IFN-c producing CD8
+ T cells (B)o ra s
frequency of CD8
+CD44
int/hi cells expressing IFN-c (C). C, The CD44 vs. IFN-c plot in the top panel is gated on CD8
+ T cells. D–E, For evaluation of
cycling CD8
+ T cells, splenocytes were stained for CD8b, CD44, and Ki-67. Data are presented as absolute number of CD8
+Ki-67
+ T cells (D)o ra s
histograms gated on CD8
+CD44
int/hi T cells (E). F, CTL assay was performed with purified splenic CD8
+ T cells cultured in presence of TLA and
irradiated feeder cells. Following incubation with
51Cr labeled infected targets at various E:T ratios, radioisotope release was assayed. The data
depicted here represents at least 2 experiments with 3–4 mice per group.
doi:10.1371/journal.pone.0010842.g001
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IL7Ra had no clear effect on adoptively transferred CD8
+ T cells
[18]. This suggests that absence of IL-15 or IL-7 alone does not
affect CD8
+ T cell activation during acute Toxoplasmosis.
However, IL-7 blockade in KO mice attenuated CD44 up-
regulation on CD8
+ T cells (Figure 1A), implying that absence of
both the cytokines affects their activation.
As previous studies including those from our laboratory have
demonstrated that IFN-c producing CD8
+ T cells play a crucial
role in maintaining long-term immunity against T. gondii [4,19],
we determined if presence of both IL-7 and IL-15 are needed for
optimal induction of this subset in response to antigenic
stimulation. As shown in Figure 1B, while reduced number of
CD8
+IFNc
+ T cells was observed in IL-15 deficient mice, IL-7
depleted WT mice did not exhibit a defect in the generation of this
population. Interestingly, anti IL-7 treated KO mice exhibited a
nearly 80% decrease in absolute number of CD8
+IFNc
+ T cells
vis-a `-vis untreated controls (Figure 1B). However, the reduced
number of CD8
+IFNc
+ T cells could be a downstream
consequence of lower number of activated CD8
+ T cells. To
address this possibility we measured IFN-c expression in
CD8
+CD44
int/hi population in the infected animals. As shown in
Figure 1C (top panel), majority of the IFN-c producing CD8
+ T
cells were present in the CD44
int/hi subset. In agreement with our
results in Figure 1B, IL-7 blockade in IL-15 KO mice reduced the
frequency of IFN-c expressing cells in the CD44
int/hi subset
(Figure 1C). In contrast to our data in Figure 1B, IL-15 deficiency
alone did not down-regulate the frequency of IFN-c producing
CD8
+ T cells (Figure 1C). This apparent discrepancy can be
explained by the fact that IL-15 is needed for the survival of both
memory and naı ¨ve CD8
+ T cells and absence of this cytokine, can
affect the survival of both these subsets [20]. This is further
supported by another study, in which continuous treatment of
thymectomized mice with anti IL-7R antibody led to only minor
reduction in naı ¨ve CD8
+ T cells, suggesting that factors other than
IL-7 can support the survival of these cells [21].
As role of IL-7 and IL-15 alone in mediating CD8
+ T cell
proliferation has been recently demonstrated in non infectious
disease models [22,23], next, we determined if reduced CD8
+ T
cell response in anti IL-7 treated KO mice infected with T. gondii is
due to defect in their proliferative ability. To address this issue,
absolute number of CD8
+ T cells in the splenic population was
measured by intracellular staining. Ki-67, a protein expressed in
non-G0 phases of cell cycle has been shown to be essential for cell
Figure 2. Simultaneous deficiency of IL-7 and IL-15 results in poor development of IL-7Ra
hiBcl-2
+CD8
+ T cells. WT, KO, anti IL-7 treated
WT and anti IL-7 treated KO mice were sacrificed at day 14 p.i. A–D, Splenocytes were surface stained for CD8b, CD44 and CD127, followed by
intracellular staining for Bcl-2. A, Bcl-2 MFI of CD8
+CD44
int/hi T cells is shown as bar graph. B–D, Data of activated CD8
+ T cell subsets are presented as
Bcl-2 vs. CD127 density-contour plot (B) or as bar graphs of Bcl-2 MFI of CD8
+CD44
int/hiCD127
hi T cells (C) or CD8
+CD44
int/hiCD127
hiBcl-2
+ (D). The
experiment was performed at least twice with similar results. The data is representative of one experiment with 4 mice per group.
doi:10.1371/journal.pone.0010842.g002
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with parasite exhibited a significant decrease in the absolute
number of actively cycling splenic CD8
+ T cells that was severely
exacerbated by anti IL-7 antibody treatment of these mice. To
further investigate the proliferation of activated CD8
+ T cells, we
assessed the percentage of CD8
+Ki-67
+ T cells by gating on
CD8
+CD44
int/hi population. Similar to the observations made in
Figure 1C, absence of IL-15 alone did not significantly alter the
percentage of CD8
+CD44
int/hi Ki-67
+ T cells (Figure 1E). In
agreement with observations made above, IL-7 depletion of KO
mice led to substantial decrease in cycling CD8
+CD44
int/hi T cells.
Conversely, anti IL-7 treatment of WT mice failed to make any
significant changes in this subset of CD8
+ T cells (Figure 1E).
ApartfromIFN-cproduction,anothercriticaleffectorfunctionof
CD8
+ T cells is their ability to lyse infected target cells [25].
Cytotoxic function of immune CD8
+ T cells generated in response
to T. gondii infection has been well demonstrated by studies
conducted by our group and other laboratories [6,25,26]. To
determine the effect of IL-7/IL-15 on the development of CTL
response against T. gondii, infected WT and KO animals were
treated anti IL-7 antibody. As expected, purified CD8
+ T cells from
saline treated WT mice exhibited a strong CTL activity, which was
unaltered by anti IL-7 treatment of these animals (Figure 1F).
Similarly, normal CTL activity in response to T. gondii infection was
observed in KO mice. However, administration of anti IL-7 to the
KO animals severely reduced their CTL response (Figure 1F)
further emphasizing that the absence of both IL-7 and IL-15 can
cause a severe impediment in the development of antigen-specific
CD8
+ T cell immunity against Toxoplasma infection.
Splenic CD8
+ T cells from anti IL-7 antibody treated KO
mice exhibit sub-optimal Bcl-2 up-regulation
Development of a potent CD8
+ T cell response involves an
appropriate balance between cell survival, apoptosis and prolifer-
ation [27,28,29,30]. One of the most widely studied regulators of
cell survival is Bcl-2, an anti-apoptotic molecule [27]. Over-
expression of Bcl-2 has been shown to prevent apoptosis by
blocking the release of cytochrome c from mitochondria [31].
Previous studies using Bcl-2
2/2 mice have clearly demonstrated
the critical role played by this molecule in peripheral T cell
maintenance [32]. As expression of Bcl-2 and IL-7R has been
associated with long-lived CD8
+ T cell development, we studied
expression of these two molecules on CD8
+ T cells of T. gondii
infected mice [33]. Activated CD8
+CD44
int/hi T cell population
from infected animals was assayed for Bcl-2 by intracellular
staining. As shown in Figure 2A, irrespective of anti IL-7
treatment, similar levels of Bcl-2 expression on the CD8
+
CD44
int/hi T cells of WT mice was observed. However, KO mice
exhibited a modest reduction in the levels of this molecule, which
was severely down-regulated in anti IL-7 antibody treated KO
mice (Figure 2A).
Recent studies have demonstrated that memory precursor
effector cells exhibit high levels of Bcl-2 and can be identified by
IL-7Ra
hi (CD127) expression [33]. In the T. gondii model, since
preferential CD127 expression has been shown to be a hallmark of
memory precursor CD8
+ T cells i.e. effector CD8
+ T cells that are
destined to become memory CD8
+ T cells [25], lower Bcl-2
expression in anti IL-7 treated KO mice could be due to decreased
frequency of CD127
hi cells in these animals. To address this
possibility we performed a 4-color FACS analysis and examined
the CD8
+CD44
int/hi subset for Bcl-2 and CD127 expression.
While we observed a similar percentage of CD44
int/hi cells
expressing CD127 in WT animals treated with or without
antibody, (Figure 2B), anti IL-7 treatment of KO animals showed
Figure 3. Lack of IL-7 and IL-15 results in suboptimal expansion
of BrdU labeled CD8
+ T cells. A, KO mice treated with anti IL-7 or
saline were injected with BrdU i.p. daily between day 2 and day 5 p.i.
Splenocytes were harvested at day 6 and day 14 p.i. and analyzed for
BrdU labeled CD8
+ T cells as stated in Materials and Methods. b–c, Data
are presented as absolute number (B) or percentage (C) of BrdU labeled
of CD8
+ T cells. The data depicted represents one of two experiments
with similar results. Each group in the experiment had at least 3 mice.
doi:10.1371/journal.pone.0010842.g003
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other groups. As shown in Figure 2B, in all the experimental
groups, majority of Bcl-2 expressing cells belonged to the CD127
hi
population. Moreover, while moderate reduction in percentage of
Bcl-2
+ cells within CD127
hi population of KO mice was noted,
anti IL-7 treatment further down-regulated this response
(Figure 2B). Conversely, IL-7 depletion of WT animals did not
significantly alter the frequency of CD127
hi cells expressing Bcl-2.
Since majority of Bcl-2
+ cells co-expressed high levels of CD127,
we wanted to evaluate if the patterns of Bcl-2 expression levels in
CD127
hi subset were similar to CD44
int/hi cells. In agreement with
observations made in Figure 2A and 2B, lack of IL-15 or IL-7
resulted in moderate or no reduction in Bcl-2 levels respectively
(Figure 2C). However, IL-7 depletion in KO mice caused a
significant decrease of Bcl-2 MFI in CD8
+CD44
int/hi CD127
hi T
cells. Next we evaluated the differences in the expression of Bcl-2
molecule within CD127
hiBcl-2
+ population of WT and KO
animals treated with or without antibody. As shown in Figure 2D,
lack of either IL-15 or IL-7 did not affect Bcl-2 up-regulation in
CD8
+CD44
int/hiCD127
hiBcl-2
+ T cells, while absence of both
cytokines severely down-regulated the expression of this molecule
in this subset. Combined, our data suggests that in absence of both
IL-7 and IL-15 development of CD8
+CD127
hiBcl2
+ T cell subset
is severely compromised.
Lack of both IL-7 and IL-15 results in suboptimal
expansion of BrdU labeled splenic CD8
+ T cells in T.
gondii infected animals
Since Bcl-2 has been shown to be critical for peripheral CD8
+ T
cell survival, reduced effector functions of CD8
+CD44
int/hi cell in
anti IL-7 treated KO mice could be due to decreased survival of
these cells. To address this issue, we adopted a BrdU ‘‘pulse-
chase’’ approach that would permit enrichment of antigen-specific
cells in the BrdU labeled subset. This strategy would allow us to
study maturation, effector functions and survival of antigen-
specific CD8
+ T cells. Antibody treated and untreated KO mice
were injected with BrdU for 4 days, then subsequently CD8
+ T
cells response in the BrdU labeled population was measured at day
6 and 14 p.i. (Figure 3A). As shown in Figure 3B and Figure 3C,
anti IL-7 treatment of the knock out animals did not have an effect
on absolute number or frequency of BrdU
+ CD8
+ T cells at day 6
p.i. However, at day 14 p.i., continued blockade with anti IL-7
dramatically reduced both the absolute number and frequency of
these cells. Interestingly, BrdU
+ CD8
+ T cell response in the
antibody treated group at day 14 p.i. was also significantly lower
than that at day 6 p.i.. This data suggests that continued absence
of both IL-7 and IL-15 leads to sub-optimal CD8
+ T cell response
in T. gondii infected animals.
Blockade of IL-7 in KO mice does not severely impair
maturation or IFN-c production or cell cycling of BrdU
+
CD8
+ T cells
Next, we wanted to address if reduced CD8
+ T cell response
observed in bulk population (Figure 1) was also evident in the
Figure 4. BrdU labeled CD8
+ T cells in IL-7 depleted KO mice
show unimpaired response. Splenocytes from BrdU injected anti IL-
7 or saline treated mice KO were harvested at day 6 and day 14 p.i.
Surface and intracellular staining was performed as described in
Materials and Methods. a–c, Data are presented as histograms depicting
the percentage of CD44
hi (A), IFN-c (B) and Ki-67 (C) expression in BrdU
+
and BrdU
2 CD8
+ T cells. A–C, The data shown here is representative of
one of two similar experiments with 3–4 mice per group.
doi:10.1371/journal.pone.0010842.g004
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BrdU
+ CD8
+ T cells in both antibody treated and untreated KO
animals expressed high levels of CD44. Similarly, no difference in
the expression of this activation marker in the BrdU labeled subset
of anti IL-7 antibody and untreated animals was observed at day
14 p.i. (Figure 4A), suggesting that absence of IL-7 in KO mice
does not inhibit CD8
+ T cell maturation. As in vitro addition of IL-
7 to human T cells has been shown to up-regulate IFN-c
expression in a dose dependent manner [34], next we determined
if neutralization of IL-7 affects the IFN-c production of BrdU
labeled CD8
+ T cells. As shown in Figure 4B, irrespective of IL-7
depletion, 30–34% of BrdU
+ CD8
+ T cells expressed IFN-c at day
6 p.i. and this percentage increased to 61–66% at day 14 p.i..
Since a recent study in LCMV model has shown that IL-7 has a
role in CD8
+ T cell proliferation, we examined whether a reduced
frequency of BrdU labeled CD8
+ T cells in the cytokine depleted
animals at day 14 p.i. could be attributed to reduced expansion of
these cells [35]. To determine if this is the case, Ki-67 expression
was measured by flow cytometry. As shown in Figure 4C, while
anti IL-7 treatment had no significant effect on cell cycling at day
6 p.i., moderate reduction in this group was observed at day 14 p.i.
These results suggest that attenuated proliferation as a result of IL-
7 depletion in KO mice plays a minor role in severely diminished
frequency of BrdU
+ CD8
+ T in Toxoplasma infected animals.
Blockade of IL-7 in KO mice down-regulates Bcl-2 and IL-
7Ra up-regulation of BrdU
+ CD8
+ T cells
To determine if lower Bcl-2 levels observed in the activated
phenotype (CD44
int/hi) CD8
+ T cells from anti IL-7 treated KO
mice (Figure 2) is due to reduced frequency of antigen-specific cells
in these animals, BrdU labeled cells were assayed for Bcl-2 and
CD127, hallmarks of effector cells destined to be long-lived
memory cells [33]. As shown in Figure 5A, IL-7 depletion at day 6
p.i. did not make a significant difference in the percentage or
Figure 5. Bcl-2 and IL-7Ra are downregulated in BrdU
+CD8
+ T cells from IL-7 depleted KO mice. Splenocytes from BrdU injected antibody
or saline treated KO mice were harvested at day 6 and day 14 p.i. The cells were stained for CD8b, CD127, Bcl-2 and BrdU as described in Materials and
Methods. A, The Bcl-2 vs. CD127 density-contour plots depicted on the top panel are gated on CD8
+Brdu
+ T cells (top left panel) and CD8
+BrdU
2 T cells
(top right panel). B–D, Bcl-2 MFI of CD8
+BrdU
+ T cells (B), CD8
+BrdU
+CD127
hiBcl2
+ T cells (C) and CD8
+BrdU
+CD127
hiBcl2
hi T cells (D) are presented as
bar graphs in the lower panel. The experiment was performed twice with similar results. The data is representative of one of two similar experiments
with 3–4 mice per group.
doi:10.1371/journal.pone.0010842.g005
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+CD8
+ T cell
population. Concomitant with a decrease in the percentage of
CD127
hiCD8
+ T cells, antibody blockade at day 14 p.i. caused a
reduction in Bcl-2 MFI in BrdU
+CD8
+ T cells and BrdU
+CD127-
hiCD8
+ T cells (Figure 5A–C). Interestingly, we found that
depletion of IL-7 in the KO mice led to a profound down-
regulation in the development of CD127
hiBcl-2
hi cells within
BrdU
+ population (Figure 5A), and reduction of Bcl-2 expression
within these cells was even more pronounced in the Bcl-2
hi subset
(Figure 5D). Conversely, 3 fold higher percentage of CD127
hiBcl-
2
hi population was observed in untreated control animals
(Figure 5A) and increase of Bcl-2 levels within these cells from
these animals over time correlated with an increase in CD127
expression (MFI of 218–232 to 356–367) (Figure 5A). In contrast,
anti IL-7 treatment of KO mice led to minimal increase in CD127
MFI in the above subset and expression of this molecule merely
rose from a MFI of 210–236 at day 6 p.i. to a MFI of 251–260 at
the later time point (Figure 5A). These observations demonstrate
that while lack of IL-7 or IL-15 alone has little impact on IL-7Ra
and Bcl-2 up-regulation within CD8
+ T cell population during
acute Toxoplasmosis, absence of both IL-7 and IL-15 leads to
defective expression of these molecules.
In absence of IL-7, KO mice fail to control T. gondii
infection
As mentioned earlier the role of CD8
+ T cells in immuno-
protection against T. gondii infection is well documented [1,3,19].
Since depletion of IL-7 in KO mice generated poor CD8
+ T cell
response against T. gondii infection, next we determined, if
deficiency of both these cytokines reduced the host survival
against the parasite. One day prior to infection WT and KO
animals were administered anti IL-7 antibody or equal volume of
saline via i.p. route. The treatment was subsequently continued at
3-day intervals until the termination of experiment. As shown in
Figure 6A, while 20% and 50% mortality was noted in control KO
mice and anti IL-7 treated WT mice respectively, all the animals
treated with anti IL-7 antibody succumbed to infection by day 26
p.i..
To confirm that high mortality observed in anti IL-7 treated
KO mice is due to their compromised capacity to clear parasites,
tissues (gut, spleen, liver and lung) from these animals were
analyzed for parasite load by quantitative PCR at day 14 p.i. [36].
As shown in Figure 6B, anti IL-7 treatment of KO mice severely
reduced their ability to clear infection as maximal parasite burden
was observed in the tissues of these animals. This data suggests
absence of both IL-7 and IL-15 severely impairs host resistance to
T. gondii by diminishing parasite clearance.
In absence of IL-7, IL-15
2/2 mice infected with replication
incompetent T. gondii parasites show attenuated CD8
+ T
cell response
A recent study using two photon laser microscopy has
demonstrated that memory T cells can be infected by T. gondii
by direct transfer of parasites from neighboring cells [37].
Considering the high parasite burden observed in IL-7 depleted
KO mice, poor CD8
+ T cell response in these animals might be a
direct consequence of parasitized CD8
+ T cells. In order to
circumvent this issue, we used cps1-1 parasites, a replication
incompetent strain of T. gondii, which are deficient for de novo
pyrimidine biosynthesis [38]. Using a similar IL-7 blocking
regimen, KO mice were infected with 1610
6 cps1-1 parasites
via i.p. route. At day 14 p.i. both antibody treated and untreated
controls were sacrificed and spleens assayed for CD8
+ T cell
response. As shown in Figure 7A, IL-7 depletion of naı ¨ve mice did
not produce any change in absolute number of CD8
+CD44
int/hi T
cells. Similar observations were made even with 3 fold higher doses
of the blocking antibody, suggesting that unaffected CD8
+ T cell
development in anti IL-7 treated naı ¨ve mice was not due to
incomplete IL-7 depletion (data not shown). However, similar to
observations made with replication competent parasites, antibody
treatment of cps1-1 infected KO mice severely attenuated the
CD8
+CD44
int/hi T cell response in these animals (Figure 7A).
Figure 6. IL-7 depleted KO mice rapidly succumb to oral Toxoplasma infection. WT and KO mice treated with anti IL-7 antibody or saline
were infected per-orally with 10 cysts of T. gondii. A, Survival was monitored on a daily basis and statistical significance was calculated by Mantel-Cox
Test. B, Parasite burden was measured in liver, lung, spleen and gut by quantitative PCR at day14 post-infection. Differential parasite burden in each
tissue is statistically significant. The experiment was repeated twice with similar results and the data depicted is representative of one of two
experiments with 4–6 mice per group.
doi:10.1371/journal.pone.0010842.g006
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+ T cells upon both anti CD3
(Figure 7B) or TLA (data not shown) stimulation in cps1-1 infected
mice was also diminished as a result of anti IL-7 treatment.
However even with polyclonal anti CD3 stimulation no significant
difference in percentage of IFN-c producing CD8
+ T cells between
naive KO mice treated with or without antibody was observed
(Figure 7B). Overall, the extent of attenuation of CD8
+ IFN-c
+ T
cell response due to IL-7 depletion exhibited similar trends in both
cps1-1 and ME49 infected KO mice, suggesting that high parasite
burden in ME49 infected antibody treated KO mouse does not
significantly contribute to the decreased CD8
+ T cell response in
these animals. Significantly, considering the utility of cps1-1 as a
live attenuated vaccine, it makes our current findings particularly
relevant for improving vaccination regimens against Toxoplasma.
Discussion
The results presented in the current studies demonstrate that
both IL-7 and IL-15 play an important role in the induction of
primary CD8
+ T cell response against T. gondii infection. An
earlier report from our laboratory has pointed towards the
importance of exogenous IL-7 treatment in the generation of
primary CTL vivo, however the extent of involvement of
endogenous levels of this cytokine was not described [6]. Although,
the role of related cc cytokine IL-15, in the generation and
maintenance of long-term CD8
+ T cell immunity against T. gondii
is well established by several studies conducted in our laboratory,
importance of this cytokine in the initiation of primary CD8
+ T
cell response has not been studied [7,11,12]. In the present study
we demonstrate that while lack of IL-15 or IL-7 alone has minimal
or no impact on CD8
+ T cell development, the absence of both
cytokines severely impairs this response.
In the present study we demonstrate that depletion of IL-7 alone
did not impede the induction of primary CD8
+ T cell response in
the WT animals. Similarly, lack of IL-15 did not cause significant
deficits in CD8
+ T cell maturation, IFN-c production, prolifera-
tion and cytolytic function of infected animals. However, the
major defect caused by lack of IL-15 lay in the attenuated number
of CD8
+ T cells generated in KO mice in response Toxoplasma
challenge. In agreement with observations by Schluns et al in VSV
model, our findings strongly suggest that IL-15 is essential for
regulating CD8
+ T cell burst size during acute Toxoplasmosis,
while its role in acquisition of effector functions is minimal [9].
Interestingly, depletion of IL-7 in KO mice had a profound effect
on the generation of a potent CD8
+ T cell response in these
animals. This is manifested by their attenuated maturation and
inability of these cells to produce optimal IFN-c or proliferate or
lyse parasite infected target cells. Based on these observations it
appears that IL-7 and IL-15 together, are the key mediators of
maturation and effector function development of CD8
+ T cells
during acute T. gondii infection.
Apart from functionality and maturation, Bcl-2 mediated CD8
+
T cell survival is one of the critical determinants of optimal
response against a pathogen. Several studies have established the
important roles played by IL-7 and IL-15 respectively in mediating
Bcl-2 up-regulation in lymphocytes [39,40]. However the effect of
both these cytokines on Bcl-2 and IL-7Ra expression in CD8
+ T
cells during acute phase of infection remains understudied. In the
present study we demonstrate that IL-7 depletion alone had no
effect on Bcl-2 up-regulation which is consistent with earlier
studies conducted with Vesicular Stomatitis Virus (VSV) model of
infection [41]. Further, our data suggests that absence of IL-15
alone may play a minor role in committing CD8
+CD44
int/hi
CD127
hi T cells to express Bcl-2 during the acute phase of
infection. This is the first report that demonstrates in an infectious
disease model that lack of both IL-7 and IL-15 not only down-
regulates the development of CD127
hi subset, but also reduces the
frequency of CD127
hi cells expressing Bcl-2. Moreover, it has been
recently shown that IL-15 down-regulates pro-apoptotic Bax, an
intermediate in TRAIL mediated apoptosis pathway, and
increases anti-apoptotic molecules in CD8
+ T cells [42,43]. Hence
it is possible that in absence of both IL-7 and IL-15, lower Bcl-2
levels may be secondary to increased TRAIL mediated signaling in
these animals.
Figure 7. Cps vaccination elicits a sub-optimal CD8
+ T cells
response in IL-7 depleted KO mice. Splenocytes were harvested from
KO and anti IL-7 treated KO mice infected with 1610
6 parasites of cps1-
1 at day 14 p.i. A, Absolute number of CD8
+CD44
int/hi T cells present in
untreated or antibody treated infected or naı ¨ve KO mice is shown in the
top panel. B, For evaluation of cytokine response splenocytes were
stimulated in anti CD3 coated plates and then stained for CD8b, CD44
and IFN-c as described in Materials and Methods. The experiment was
repeated twice with similar results and the data depicted is
representative of one of two experiments with 3–4 mice per group.
doi:10.1371/journal.pone.0010842.g007
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phenotype CD8
+ T cells is that in anti IL-7 treated KO mice only
21–24% of these cells produce IFN-c in an antigen-specific
manner. Hence observations made regarding Bcl-2 or CD127
expression in activated phenotype CD8
+ T cells in the above
animals may not be as relevant to T. gondii specific response.
Moreover, the observed differences in activated CD8
+ T cell
response as a result of IL-7 depletion in KO mice could be the
result of decreased antigen-specific CD8
+ T cells due to potentially
reduced naı ¨ve CD8
+ T cell survival in the these animals. As stated
earlier, importance of IL-7 in naı ¨ve T cells survival has been
documented [44]. Although we did not observe significant
difference in absolute number or frequency of CD8
+ T cells (data
not shown) or CD8
+CD44
int/hi T cells as a result of anti IL-7
treatment in uninfected KO mice after 2 weeks of antibody
treatment, the possibility of altered survival of naı ¨ve T cells in
infected mice cannot be entirely ruled out. To circumvent this
issue, we utilized a BrdU pulse-chase approach that would enable
us to track endogenous CD8
+ T cells highly enriched for T. gondii
specific cells. Although it is possible for non-specific HP
(homeostatic proliferation) memory CD8
+ T cells to incorporate
BrdU, a recent study has shown that true memory or antigen
experienced memory phenotype CD8
+ T cells are 8 times more
efficient at expanding than HP memory T cells [45]. Our results
demonstrate that IL-7 depletion in KO mice does not affect CD8
+
T cell priming as evident by similar BrdU labeled CD8
+ T cell
response at day 6 p.i. However, lack of this cytokine prevents
optimal survival of these cells at a later time point. Interestingly,
absence of both IL-7 and IL-15 does not adversely affect CD44
expression, IFN-c production or cell cycling at either day 6 or day
14 p.i. suggesting that reduced effector function and maturation
are primarily consequences of poor survival of antigen-specific
CD8
+ T cells in these mice. This was suggested by the observation
that anti IL-7 treatment of KO mice led to decreased expression of
Bcl-2 and CD127 in the BrdU
+ population. However, considering
the high pathogen burden in these mice, it needs to be investigated
in future studies whether one of the factors contributing to poor
development of memory CD8
+ T cells in IL-7 depleted KO mice
is accelerated exhaustion of CD8
+ T cells via PD-1-PDL-1
pathway [46,47].
Apart from CD8
+ T cells, Natural Killer (NK) cells and CD4
+ T
cell produce IFN-c, a critical mediator of resistance against T.
gondii [48]. However in T. gondii infection, NK cells have been
shown to have a minimal protective role even during the acute
phase of infection [49]. Paradoxically, despite normal splenic
CD8
+ T cell response, anti IL-7 treated WT mice exhibited
elevated parasite load and mortality. This may be owing to
depressed CD8
+ T (Figure S1) cell and NK (Figure S2) cell
response noted in liver in both anti IL-7 treated WT and KO
(more severe defects) mice. Based on a recent report from our
laboratory demonstrating that NK-dendritic cell cross-talk is
critical for optimal CD8
+ T cell development [50], on-going
studies in our lab are addressing whether defective hepatic CD8
+
T cell response is secondary to sub-optimal NK cell development
and why hepatic but not splenic NK cell response is IL-15
dependent.
Although in several infectious disease models including T. gondii,
primary CD8
+ T cell response during acute infection phase has
been shown to be independent of CD4
+ T cell help, the role of
CD4
+ T cells themselves in partially mediating protection against
T. gondii cannot be discounted [51,52]. Nevertheless, we did not
observe any difference in CD4
+ T cell response between untreated
and anti IL-7 injected KO mice at day 14 p.i. (data not shown).
Thus, the above data strongly suggests that poor survival and high
parasite burden in antibody treated KO mice are primarily
consequences of sub-optimal CD8
+ T cell development in these
mice.
Since a previous study has demonstrated that IL-2 down-
regulates IL-7Ra expression on activated T cells, it is possible that
in the absence of IL-7 and IL-15, other cytokines may be involved
in down regulating CD8
+ T cell response [53]. Unlike other
pathogens, T. gondii infection does not induce a potent IL-2
response even during the acute phase of infection [6,54,55,56].
Hence, it is not surprising that no significant difference in IL-2
producing cells was noted between untreated and antibody treated
KO mice (Figure S3). In addition to IL-7, IL-15 and IL-2, IL-12 is
another important cytokine known to regulate the development of
memory CD8
+ T cell response. A recent study by Pearce et al has
demonstrated that high IL-12 levels induced during Listeria
monocytogenes infection down-regulates CD8
+ memory T cell
differentiation [57]. However, in the present study administration
of anti IL-7 to KO mice did not alter their IL-12 production or the
expression IL-12Rb1 and IL-12Rb2 by CD8
+ T cells (Figure S4).
Apart from IL-7 and IL-15, potential role of other cc family
members like IL-4 [58,59] and IL-21 [60] that have been
implicated in CD8 memory generation in other infectious disease
models, need to be considered in future investigations of memory
CD8
+ T cell development during toxoplasmosis.
Recent study by Klonowski et al with VSV using IL-7 deficient
animals has shown that CD127 and Bcl-2 up-regulation are IL-7
independent [41]. However our observations demonstrate that in
absence of IL-15, endogenous IL-7 has a non-redundant role in
mediating Bcl-2 and CD127 up-regulation. Alternatively, it is
possible that in absence of both IL-7 and IL-15, higher
dependence on related cc family member, IL-21 may decrease
CD127 and Bcl-2 expression on CD8
+ T cells [61]. Taken
together, our data suggests that IL-7 and IL-15 have overlapping
roles in mediating up-regulation of Bcl-2 and CD127 on antigen-
specific CD8
+ T cells and that differential CD127 expression does
not impede CD44 expression or effector functions during acute
phase infection.
The findings presented in the current manuscript go a long way
in understanding synergistic effect of IL-7 and IL-15 in the
development of CD8
+ T cell immunity against T. gondii infection.
However, the molecular mechanism regulating this synergism
remains to be further investigated. Preliminary studies from our
laboratory suggest that in absence of both of these cytokines there
is defective up-regulation of master transcriptional factors, T-bet
and Eomes in CD8
+ T cells (Figure S5). This defect in T-bet up-
regulation is evident as early as day 6 p.i. (Figure S5). Significance
of this down-regulated T-bet and Eomes expression will have to
await further investigation. Nevertheless, the data presented in this
manuscript provide significant insights into the combined role of
IL-7 and IL-15 in the development of CD8
+ T cell immunity
during acute Toxoplasma infection. Moreover, these findings have
important implications in understanding the use of IL-7 and IL-15
as adjuvant for therapeutic vaccination regimen against intracel-
lular pathogens where CD8
+ T cells constitute a critical
component of protective immunity.
Supporting Information
Figure S1 Anti IL-7 treated WT or KO mice exhibit attenuated
hepatic CD8
+ T cell response. A, Absolute number of CD8
+ T
cells in liver was evaluated in antibody or saline treated WT and
KO mice at day 14 pi. The data is representative of one of 2
experiments with at least 3–4 mice per group.
Found at: doi:10.1371/journal.pone.0010842.s001 (0.61 MB EPS)
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PLoS ONE | www.plosone.org 10 May 2010 | Volume 5 | Issue 5 | e10842Figure S2 Anti IL-7 treatment WT or KO mice results in
reduced hapatic NK cell response. A,B Asbolute number of NK
cells in spleen (A) and liver (B) was evaluated in antibody or saline
treated WT and KO mice. The data is representative of one of 2
experiments with at least 3–4 mice per group.
Found at: doi:10.1371/journal.pone.0010842.s002 (0.73 MB EPS)
Figure S3 Simultaneous deficiency of IL-7 and IL-15 does not
result in differential IL-2 production. A, Splenocytes from
antibody or saline treated KO mice were assessed for IL-2
production after overnight TLA stimulation. The data is
representative of one of 2 experiments with at least 3–4 mice
per group.
Found at: doi:10.1371/journal.pone.0010842.s003 (0.65 MB EPS)
Figure S4 Simultaneous deficiency of IL-7 and IL-15 does not
result in differential IL-12 production. A, Splenocytes from
antibody or saline treated WT and KO mice were assessed for
IL-12 production. B,C IL-12Rb1 (B) and IL-12Rb2 (C) expression
was evaluated on splenic CD8
+ T cells by flow cytometry. The
data is representative of one of 2 experiments with at least 3–4
mice per group.
Found at: doi:10.1371/journal.pone.0010842.s004 (4.36 MB EPS)
Figure S5 T-bet and Eomes expression are downregulated in
BrdU
+CD8
+ T cells from IL-7 depleted KO mice. Splenocytes
from BrdU injected anti IL-7 or saline treated KO mice were
harvested at day 6 and day 14 p.i. A,B T-bet (A) and Eomes (B)
expression and frequency was evaluated in both BrdU
+ and
BrdU
2 CD8
+ T cells by intracellular staining. Numbers within
brackets represent MFI. The data is representative of one of 2
experiments with at least 3–4 mice per group.
Found at: doi:10.1371/journal.pone.0010842.s005 (1.11 MB EPS)
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